Portfolio company
VedaBio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops CRISPR-based molecular diagnostic instruments and cartridges for healthcare providers, urgent care clinics and diagnostic laboratories to enable rapid testing.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Sherlock Biosciences
This company develops molecular diagnostic tests using CRISPR and synthetic biology for healthcare providers and consumers to detect infectious diseases and other health conditions.
Pictura Bio
This company develops point-of-care diagnostic tools using machine learning and microscopy to identify pathogens in respiratory samples for clinicians and healthcare providers.
Nanopath
This company develops point-of-care molecular diagnostic tests and hardware for pelvic and gynecologic infections to provide rapid results for healthcare providers and their patients.
Anvil Diagnostics
This company develops molecular blood tests to identify and quantify pathogens in hospitalised patients using digital PCR hardware.
Visby Medical
This company develops portable, single-use molecular diagnostic devices for clinicians and consumers to detect infectious diseases, including respiratory and sexual health conditions.
Videm
Videm develops a handheld diagnostic device for rapid molecular and protein detection of infectious diseases in care settings and at home.
Mammoth
This company develops CRISPR-based molecular diagnostics and gene-editing therapies for pharmaceutical partners and healthcare providers.
Septest
This company develops point-of-need blood tests for healthcare professionals to rapidly identify infection and inflammation biomarkers in patients.
